MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with O

Oxycodone + Naloxone

Oxycodone 5mg / Naloxone 2.5mg modified-release tablets

Use with caution

Stability notes for Oxycodone 5mg / Naloxone 2.5mg modified-release tablets

Light sensitive medicine. Store in light resistant container.   Moisture sensitive medicine. Store in airtight (sealed) MCA . Manufacturer recommends storing in original container.
No stability data in MCAs available.

Provenance

This recommendation is based on the products Targinact 5mg/2.5mg prolonged-release tablets (Napp Pharmaceuticals Limited)

Suppliers (6) of Oxycodone 5mg / Naloxone 2.5mg modified-release tablets
Myloxifin 5mg/2.5mg modified-release tablets (Ridge Pharma Ltd)
Sofonac 5mg/2.5mg modified-release tablets (G.L. Pharma UK Ltd)
Targinact 5mg/2.5mg modified-release tablets (CST Pharma Ltd)
Targinact 5mg/2.5mg modified-release tablets (Napp Pharmaceuticals Ltd)
Targinact 5mg/2.5mg modified-release tablets (Necessity Supplies Ltd)
Targinact 5mg/2.5mg modified-release tablets (Pilsco Ltd)

Oxycodone 10mg / Naloxone 5mg modified-release tablets

Use with caution

Stability notes for Oxycodone 10mg / Naloxone 5mg modified-release tablets

Light sensitive medicine. Store in light resistant container.   Moisture sensitive medicine. Store in airtight (sealed) MCA . Manufacturer recommends storing in original container.
No stability data in MCAs available.

Provenance

This recommendation is based on the products Targinact 10mg/5mg prolonged-release tablets (Napp Pharmaceuticals Limited) and Oxycodone/Naloxone 10mg/5mg prolonged-release tablets (Krka UK Ltd).

Suppliers (5) of Oxycodone 10mg / Naloxone 5mg modified-release tablets
Myloxifin 10mg/5mg modified-release tablets (Ridge Pharma Ltd)
Sofonac 10mg/5mg modified-release tablets (G.L. Pharma UK Ltd)
Targinact 10mg/5mg modified-release tablets (CST Pharma Ltd)
Targinact 10mg/5mg modified-release tablets (Napp Pharmaceuticals Ltd)
Targinact 10mg/5mg modified-release tablets (Necessity Supplies Ltd)

Oxycodone 20mg / Naloxone 10mg modified-release tablets

Use with caution

Stability notes for Oxycodone 20mg / Naloxone 10mg modified-release tablets

Light sensitive medicine. Store in light resistant container.   Moisture sensitive medicine. Store in airtight (sealed) MCA . Manufacturer recommends storing in original container.
No stability data in MCAs available.

Provenance

This recommendation is based on the products Targinact 20mg/10mg prolonged-release tablets (Napp Pharmaceuticals Limited) and Oxycodone/Naloxone 20mg/10mg prolonged-release tablets (Krka UK Ltd).

Suppliers (8) of Oxycodone 20mg / Naloxone 10mg modified-release tablets
Myloxifin 20mg/10mg modified-release tablets (Ridge Pharma Ltd)
Oxycodone 20mg / Naloxone 10mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Oxycodone 20mg / Naloxone 10mg modified-release tablets (Krka UK Ltd)
Sofonac 20mg/10mg modified-release tablets (G.L. Pharma UK Ltd)
Targinact 20mg/10mg modified-release tablets (CST Pharma Ltd)
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd)
Targinact 20mg/10mg modified-release tablets (Necessity Supplies Ltd)
Targinact 20mg/10mg modified-release tablets (Pilsco Ltd)

Oxycodone 40mg / Naloxone 20mg modified-release tablets

Use with caution

Stability notes for Oxycodone 40mg / Naloxone 20mg modified-release tablets

Light sensitive medicine. Store in light resistant container.   Moisture sensitive medicine. Store in airtight (sealed) MCA . Manufacturer recommends storing in original container.
No stability data in MCAs available.

Provenance

This recommendation is based on the products Targinact 40mg/20mg prolonged-release tablets (Napp Pharmaceuticals Limited) and Oxycodone/Naloxone 40mg/20mg prolonged-release tablets (Krka UK Ltd).

Suppliers (7) of Oxycodone 40mg / Naloxone 20mg modified-release tablets
Myloxifin 40mg/20mg modified-release tablets (Ridge Pharma Ltd)
Oxycodone 40mg / Naloxone 20mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Oxycodone 40mg / Naloxone 20mg modified-release tablets (Krka UK Ltd)
Sofonac 40mg/20mg modified-release tablets (G.L. Pharma UK Ltd)
Targinact 40mg/20mg modified-release tablets (CST Pharma Ltd)
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd)
Targinact 40mg/20mg modified-release tablets (Necessity Supplies Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.